David D Chang's Net Worth
$27.6 Million
Who is David D Chang?
David D Chang has an estimated net worth of $27.6 Million. This is based on reported shares across multiple companies, which include Allogene Therapeutics, Inc., and Kite Pharma, Inc..
SEC CIK
David D Chang's CIK is 0001611024
Past Insider Trading and Trends
2015 was David D Chang's most active year for acquiring shares with 10 total transactions. David D Chang's most active month to acquire stocks was the month of February. 2017 was David D Chang's most active year for disposing of shares, totalling 28 transactions. David D Chang's most active month to dispose stocks was the month of September. 2024 saw David D Chang paying a total of $1,000,001.20 for 1,786,163 shares, this is the most they've acquired in one year. In 2017 David D Chang cashed out on 670,050 shares for a total of $42,606,228.59, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Allogene Therapeutics, Inc. (ALLO) Snapshot price: $2.39
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +7.72% | 344.83K |
$2.90 | $1,000,001.20 | 4.81M |
May 16
| |||
Form 4
| -1.18% | -53.39K |
$4.33 | -$231,191.69 | 4.47M |
Mar 14
| |||
Form 4
| +7.57% | 317.8K |
—
|
—
| 4.51M |
Jan 25
| |||
Form 4
| +84.80% | 1.92M |
—
|
—
| 4.19M |
Mar 22
| |||
Form 4
| -0.97% | -22.34K |
$5.56 | -$124,210.40 | 2.27M |
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 23
| |||
Form 4
| -1.02% | -23.65K |
$7.65 | -$180,878.82 | 2.29M |
Mar 15
| |||
Form 4
| +1.20% | 27.41K |
$18.22 | $499,410.20 | 2.31M |
May 24
| |||
Form 4/A
| +31.65% | 411.56K |
—
|
—
| 1.71M |
Aug 31
| |||
Form 4
| +3.65% | 80.45K |
—
|
—
| 2.28M |
Mar 26
| |||
Form 4
| -0.92% | -20.51K |
$38.57 | -$791,270.51 | 2.2M |
Mar 15
| |||
Form 4
| +22.70% | 874.43K |
—
|
—
| 4.73M |
Scheduled
|
Mar 18 - Apr 24
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 18
| |||
Form 4
| -0.46% | -20.34K |
$19.65 | -$392,615.23 | 4.43M |
Mar 16
| |||
Form 4
| +0.55% | 18.79K |
—
|
—
| 3.43M |
Scheduled
|
Mar 4
| ||
Form 4
| +0.55% | 18.79K |
—
|
—
| 3.41M |
Scheduled
|
Nov 19
| ||
Form 4
| +0.56% | 18.79K |
—
|
—
| 3.39M |
Scheduled
|
Oct 25
| ||
Form 4
| +0.56% | 18.79K |
—
|
—
| 3.37M |
Scheduled
|
Sep 23
| ||
Form 4
| +0.56% | 18.79K |
—
|
—
| 3.35M |
Scheduled
|
Sep 5
| ||
Form 4
| +0.57% | 18.79K |
—
|
—
| 3.33M |
Scheduled
|
Jul 18
| ||
Form 4
| +0.50% | 16.54K |
—
|
—
| 3.31M |
Scheduled
|
Jun 18 - Jul 10
| ||
Form 4
| +1.06% | 11.75K |
—
|
—
| 1.13M |
Scheduled
|
May 13
| ||
Form 4
| +1.07% | 11.75K |
—
|
—
| 1.11M |
Scheduled
|
Apr 26
| ||
Form 4
| +8.67% | 173K |
—
|
—
| 2.17M |
Mar 13
| |||
Form 4
| +2.31% | 69.95K |
$18.00 | $720,000.00 | 3.1M |
Oct 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Kite Pharma, Inc. No price found
EVP, R&D, Chief Medical Off.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -57.42K |
$180.00 |
—
|
0
|
Sep 11 - Oct 3
| |||
Form 4
| +14.05% | 7.07K |
$179.66 | -$1,424,195.74 | 57.42K |
Sep 25
| |||
Form 4
|
—
|
0
|
$44.49 | -$1,503,943.80 | 50.16K |
Scheduled
|
May 1
| ||
Form 4
|
—
|
0
|
$44.22 | -$1,493,065.56 | 50.16K |
Scheduled
|
Apr 3
| ||
Form 4
|
—
|
0
|
$43.03 | -$4,336,041.00 | 50.16K |
Scheduled
|
Mar 1
| ||
Form 4
| +98.71% | 24.8K |
—
|
—
| 49.92K |
Dec 22
| |||
Form 4
| -6.64% | -1.79K |
$50.86 | -$90,937.68 | 25.12K |
Dec 20
| |||
Form 4
| +267.96% | 18.5K |
—
|
—
| 25.4K |
Dec 17
| |||
Form 4
|
—
|
0
|
$43.46 | -$2,252,404.00 | 6.9K |
Scheduled
|
Nov 10
| ||
Form 4
|
—
|
0
|
$38.99 | -$494,238.89 | 6.9K |
Scheduled
|
Nov 2
| ||
Form 4
|
—
|
0
|
$31.00 | -$371,294.00 | 6.9K |
Scheduled
|
Oct 1
| ||
Form 4
|
—
|
0
|
$30.95 | -$370,447.00 | 6.9K |
Scheduled
|
Sep 3 - Sep 8
| ||
Form 4
|
—
|
0
|
$39.50 | -$502,189.22 | 6K |
Scheduled
|
Aug 3
| ||
Form 4
|
—
|
0
|
$34.41 | -$423,727.56 | 6K |
Scheduled
|
Jul 1
| ||
Form 4
| +200.00% | 4K |
$33.67 | -$317,695.51 | 6K |
Scheduled
|
Jun 25 - Jun 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |